Adam C. Vilmar

Copenhagen, 5073, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

Journal: Leukemia & lymphoma
Published: October 16, 2023

Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.

Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.

Journal: Leukemia & lymphoma
Published: June 09, 2023

Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.

Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.

Journal: British journal of haematology
Published: June 14, 2022

A 87-year-old woman was run down by a hit-and-run driver and cured of malignant lymphoma

A 87-year-old woman was run down by a hit-and-run driver and cured of malignant lymphoma

Journal: Ugeskrift for laeger
Published: December 15, 2016

Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.

Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.

Journal: Anticancer research
Published: June 13, 2014

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial.

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 06, 2012

Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial.

Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 22, 2011

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 11, 2011

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives.

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: March 02, 2011

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial.

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 25, 2010

ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial.

ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial.

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 06, 2010

Severe Haemophilus influenzae b infection in healthy male adult

Severe Haemophilus influenzae b infection in healthy male adult

Journal: Ugeskrift for laeger
Published: October 01, 2008
Showing 1-12 of 13

Last Updated: 09/26/2026